1. Home
  2. PRAX vs CRUS Comparison

PRAX vs CRUS Comparison

Compare PRAX & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$322.54

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$150.64

Market Cap

7.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
CRUS
Founded
2015
1984
Country
United States
United States
Employees
N/A
1668
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.6B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
PRAX
CRUS
Price
$322.54
$150.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$572.13
$157.00
AVG Volume (30 Days)
548.0K
531.6K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.83
EPS
N/A
7.85
Revenue
N/A
$1,997,379,000.00
Revenue This Year
N/A
$7.12
Revenue Next Year
$7,758.26
$0.49
P/E Ratio
N/A
$19.10
Revenue Growth
N/A
5.34
52 Week Low
$37.25
$92.02
52 Week High
$366.52
$180.42

Technical Indicators

Market Signals
Indicator
PRAX
CRUS
Relative Strength Index (RSI) 54.07 43.06
Support Level $282.49 $139.43
Resistance Level $344.07 $154.90
Average True Range (ATR) 21.29 4.86
MACD 2.92 -0.13
Stochastic Oscillator 54.65 31.77

Price Performance

Historical Comparison
PRAX
CRUS

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.

Share on Social Networks: